STINGRAY THERAPEUTICS, INC.: A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab

STINGRAY THERAPEUTICS, INC. (Houston, Texas): A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab. Its award of $1,460,952 is top-decile (92nd percentile of 10,712 records). Dated 50 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

award: $1,460,952 · 92th percentile of 10,712 NihBiotechGrantPulse records · 3.6x the median

Free preview: all 10 published fields of this record are shown below. Locked: 499 related TX NihBiotechGrantPulse records and the 5-column CSV export.

FieldValue
OrganizationSTINGRAY THERAPEUTICS, INC.
LocationHOUSTON, TX
ProjectA Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab
Project number5R44CA278144-04
MechanismR44
InstituteNational Cancer Institute
Award$1,460,952
Awarded2026-09-16
Project period2025-08-14 to 2028-07-31
UEIXNADTMZYJMP5
award percentile92th of 10,712 (median $407,048, 3.6x median)
Peer records CSV (500 TX records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch STINGRAY THERAPEUTICS, INC.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock STINGRAY THERAPEUTICS + 500 TX peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL

  • Source agency: NIH RePORTER (newly awarded projects)
  • Record date: 2026-09-16
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all TX records free →

Top NihBiotechGrantPulse records (TX first): UNIVERSITY OF TX MD ANDERSON CAN CTR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · BAYLOR COLLEGE OF MEDICINE · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · Browse all by state and category →

LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: STINGRAY THERAPEUTICS, INC. and 806 Texas peers

  • Texas NihBiotechGrantPulse records like this one: 806
  • STINGRAY THERAPEUTICS, INC.'s award: 92nd percentile of 10,712 records
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every Texas peer: $161,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more NihBiotechGrantPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

70 / 100 Lab Budget Score

  • Award of $1M or more.
  • Research or center grant: supplies, instruments and services budget.

What is the NihBiotechGrantPulse record for STINGRAY THERAPEUTICS, INC. in Houston, Texas?

STINGRAY THERAPEUTICS, INC. received an NIH award of $1,460,952 on 2026-09-16: A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab.

How does STINGRAY THERAPEUTICS, INC. compare to other Texas NihBiotechGrantPulse records?

This is a top-decile record: its award of $1,460,952 is 3.6x the median of $407,048 across 10,712 records. It is 50 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.

STINGRAY THERAPEUTICS, INC. vs. top 3 peers

OrganizationLocationAmountPercentileRecord date
STINGRAY THERAPEUTICS, INC.HOUSTON, TX1,460,95292nd2026-09-16
BAYLOR COLLEGE OF MEDICINEHOUSTON, TX1,286,32391st2026-09-17
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTONHOUSTON, TX1,661,99594th2026-09-17
CONSTANTIAM BIOSCIENCES INC.KATY, TX1,252,24090th2026-09-17

Related records

NihBiotechGrantPulse: records in Texas NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)

More Texas public-record feeds

Texas Active Franchise Taxpayers Pulse in Texas Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in Texas Texas Food Distribution Program Entitlements Pulse in Texas New, Terminating & Large 401(k) Plans from Form 5500 Filings in Texas New WARN Act Layoff & Closure Notices with Headcount and Site Address in Texas Texas Active insurance company appointments for agents and adjusters Pulse in Texas SEC 8-K Corporate Trigger Events in Texas Nursing Home Inspection Deficiencies by State & Severity in Texas

How to monitor STINGRAY THERAPEUTICS, INC. and peer small business sbir/sttr (r41-r44, u43-u44) records

Get new NihBiotechGrantPulse records like STINGRAY THERAPEUTICS, INC. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together